Literature DB >> 19776595

Maternal serum activin a at 11-13 weeks of gestation in hypertensive disorders of pregnancy.

Ranjit Akolekar1, Adolfo Etchegaray, Yi Zhou, Nerea Maiz, Kypros H Nicolaides.   

Abstract

OBJECTIVES: To investigate whether the maternal serum concentration of activin A at 11-13 weeks of gestation in pregnancies that subsequently develop hypertensive disorders is different from those with a normal outcome and to examine whether any possible differences are related to uterine artery pulsatility index (PI), serum pregnancy-associated plasma protein A (PAPP-A) and serum tumor necrosis factor-alpha receptor-1 (TNF-R1).
MATERIAL AND METHODS: Serum activin A, TNF-R1, PAPP-A and uterine artery PI were determined in a case-control study of 126 cases that developed preeclampsia, 88 that developed gestational hypertension and 214 controls.
RESULTS: In preeclampsia, compared to controls, uterine artery PI, serum activin A and serum TNF-R1 were higher and serum PAPP-A was lower. In gestational hypertension, compared to controls, serum activin A was higher but uterine artery PI, serum PAPP-A and serum TNF-R1 were not significantly different. There were no significant associations between serum activin A and either uterine artery PI or serum TNF-R1 in either the hypertensive groups or the controls. DISCUSSION: The data do not support the hypothesis linking activin A with impaired trophoblastic invasion of the maternal spiral arteries, placental hypoxia and the release of cytokines which in turn cause endothelial dysfunction and the development of the clinical symptoms of the disease. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19776595     DOI: 10.1159/000235878

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  6 in total

Review 1.  The genetics of pre-eclampsia and other hypertensive disorders of pregnancy.

Authors:  Paula J Williams; Fiona Broughton Pipkin
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2011-03-22       Impact factor: 5.237

2.  External validation of prognostic models predicting pre-eclampsia: individual participant data meta-analysis.

Authors:  Kym I E Snell; John Allotey; Melanie Smuk; Richard Hooper; Claire Chan; Asif Ahmed; Lucy C Chappell; Peter Von Dadelszen; Marcus Green; Louise Kenny; Asma Khalil; Khalid S Khan; Ben W Mol; Jenny Myers; Lucilla Poston; Basky Thilaganathan; Anne C Staff; Gordon C S Smith; Wessel Ganzevoort; Hannele Laivuori; Anthony O Odibo; Javier Arenas Ramírez; John Kingdom; George Daskalakis; Diane Farrar; Ahmet A Baschat; Paul T Seed; Federico Prefumo; Fabricio da Silva Costa; Henk Groen; Francois Audibert; Jacques Masse; Ragnhild B Skråstad; Kjell Å Salvesen; Camilla Haavaldsen; Chie Nagata; Alice R Rumbold; Seppo Heinonen; Lisa M Askie; Luc J M Smits; Christina A Vinter; Per Magnus; Kajantie Eero; Pia M Villa; Anne K Jenum; Louise B Andersen; Jane E Norman; Akihide Ohkuchi; Anne Eskild; Sohinee Bhattacharya; Fionnuala M McAuliffe; Alberto Galindo; Ignacio Herraiz; Lionel Carbillon; Kerstin Klipstein-Grobusch; Seon Ae Yeo; Joyce L Browne; Karel G M Moons; Richard D Riley; Shakila Thangaratinam
Journal:  BMC Med       Date:  2020-11-02       Impact factor: 8.775

3.  Early detection of maternal risk for preeclampsia.

Authors:  B Mikat; A Gellhaus; N Wagner; C Birdir; R Kimmig; A Köninger
Journal:  ISRN Obstet Gynecol       Date:  2012-07-17

4.  The role of genetics in pre-eclampsia and potential pharmacogenomic interventions.

Authors:  Paula Juliet Williams; Linda Morgan
Journal:  Pharmgenomics Pers Med       Date:  2012-01-20

5.  Association Between Endothelial Nitric Oxide Synthase (eNOS) -786 T/C and 27-bp VNTR 4b/a Polymorphisms and Preeclampsia Development.

Authors:  Tamara Sljivancanin Jakovljevic; Olivera Kontic-Vucinic; Nadja Nikolic; Jelena Carkic; Jelena Stamenkovic; Ivan Soldatovic; Jelena Milasin
Journal:  Reprod Sci       Date:  2021-05-27       Impact factor: 3.060

6.  Co-expression network analysis and genetic algorithms for gene prioritization in preeclampsia.

Authors:  Eduardo Tejera; João Bernardes; Irene Rebelo
Journal:  BMC Med Genomics       Date:  2013-11-12       Impact factor: 3.063

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.